Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Augusto Miravalle to Multiple Sclerosis

This is a "connection" page, showing publications Augusto Miravalle has written about Multiple Sclerosis.

 
Connection Strength
 
 
 
1.345
 
  1. Miravalle AA. Guidelines and best practices for appropriate use of dalfampridine in managed care populations. Am J Manag Care. 2011 May; 17 Suppl 5 Improving:S154-60.
    View in: PubMed
    Score: 0.278
  2. Miravalle A, Corboy JR. Therapeutic options in multiple sclerosis: five new things. Neurology. 2010 Nov 02; 75(18 Suppl 1):S22-7.
    View in: PubMed
    Score: 0.268
  3. Miravalle A, Jensen R, Kinkel RP. Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch Neurol. 2011 Feb; 68(2):186-91.
    View in: PubMed
    Score: 0.267
  4. Alvarez E, Nair KV, Hoyt BD, Seale RA, Sillau S, Miravalle A, Engebretson E, Schurr B, Corboy JR, Vollmer TL, Honce JM. Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls. Mult Scler Relat Disord. 2021 Oct; 55:103170.
    View in: PubMed
    Score: 0.141
  5. Swanson CW, Proessl F, Stephens JA, Miravalle AA, Fling BW. Non-invasive brain stimulation to assess neurophysiologic underpinnings of lower limb motor impairment in multiple sclerosis. J Neurosci Methods. 2021 05 15; 356:109143.
    View in: PubMed
    Score: 0.138
  6. Korb PJ, Miravalle A. Coding in Multiple Sclerosis and Other Demyelinating Diseases. Continuum (Minneap Minn). 2016 06; 22(3):951-9.
    View in: PubMed
    Score: 0.099
  7. Kala M, Miravalle A, Vollmer T. Recent insights into the mechanism of action of glatiramer acetate. J Neuroimmunol. 2011 Jun; 235(1-2):9-17.
    View in: PubMed
    Score: 0.069
  8. Berger JR, Centonze D, Comi G, Confavreux C, Cutter G, Giovannoni G, Gold R, Hartung HP, Lublin F, Miravalle A, Montalban X, O'Connor P, Olsson T, Polman CH, Stuve O, Wolinsky JS, Ziemssen T. Considerations on discontinuing natalizumab for the treatment of multiple sclerosis. Ann Neurol. 2010 Sep; 68(3):409-11.
    View in: PubMed
    Score: 0.066
  9. Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, Corboy J, Vollmer T. Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab. J Neuropathol Exp Neurol. 2012 Jul; 71(7):604-17.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)